Role of thromboxane-dependent platelet activation in venous thrombosis: Aspirin effects in mouse model

Pharmacological Research

Volumn 107, Issue , 2016, Pages 415-425

  Tarantino, Eva ^a   Amadio, Patrizia ^a   Squellerio, Isabella ^a   Porro, Benedetta ^a   Sandrini, Leonardo ^a   Turnu, Linda ^a   Cavalca, Viviana ^a,b   Tremoli, Elena ^a   Barbieri, Silvia S ^a  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Aspirin; NETs; Thromboxane; Tissue factor; Venous thrombosis

Indexed keywords

2,3 DINORTHROMBOXANE B2; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ACETYLSALICYLIC ACID; FIBRIN; THROMBOPLASTIN; THROMBOXANE; ANTITHROMBOCYTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EXTRACELLULAR TRAP; INHIBITION KINETICS; MALE; MEMBRANE MICROPARTICLE; MONOCYTE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; THROMBOCYTE ACTIVATION; VEIN THROMBOSIS; ANIMAL; DISEASE MODEL; DRUG EFFECTS; INFERIOR CAVA VEIN; METABOLISM; NEUTROPHIL; SURGERY; THROMBOCYTE; VENOUS THROMBOSIS;

ANIMALS; ASPIRIN; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; DISEASE MODELS, ANIMAL; MALE; MICE; NEUTROPHILS; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; THROMBOPLASTIN; THROMBOXANES; VENA CAVA, INFERIOR; VENOUS THROMBOSIS;

EID: 84962916628     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2016.04.001     Document Type: Article

References (35)

1. P.S. Wells, M.A. Forgie, and M.A. Rodger Treatment of venous thromboembolism JAMA 311 2014 717 728
2. C. Becattini, G. Agnelli, A. Schenone, S. Eichinger, E. Bucherini, M. Silingardi, M. Bianchi, M. Moia, W. Ageno, M.R. Vandelli, E. Grandone, and P. Prandoni Aspirin for preventing the recurrence of venous thromboembolism N. Engl. J. Med. 366 2012 1959 1967
3. T.A. Brighton, J.W. Eikelboom, K. Mann, R. Mister, A. Gallus, P. Ockelford, H. Gibbs, W. Hague, D. Xavier, R. Diaz, A. Kirby, and J. Simes Low-dose aspirin for preventing recurrent venous thromboembolism N. Engl. J. Med. 367 2012 1979 1987
4. J. Simes, C. Becattini, G. Agnelli, J.W. Eikelboom, A.C. Kirby, R. Mister, P. Prandoni, and T.A. Brighton Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration Circulation 130 2014 1062 1071
5. C. Sakata, T. Kawasaki, Y. Kato, M. Abe, K. Suzuki, M. Ohmiya, T. Funatsu, Y. Morita, and M. Okada ASP6537 a novel highly selective cyclooxygenase-1 inhibitor, exerts potent antithrombotic effect without aspirin dilemma Thromb. Res. 132 2013 56 62
6. M.L. von Bruhl, K. Stark, A. Steinhart, S. Chandraratne, I. Konrad, M. Lorenz, A. Khandoga, A. Tirniceriu, R. Coletti, M. Kollnberger, R.A. Byrne, I. Laitinen, A. Walch, A. Brill, S. Pfeiler, D. Manukyan, S. Braun, P. Lange, J. Riegger, J. Ware, A. Eckart, S. Haidari, M. Rudelius, C. Schulz, K. Echtler, V. Brinkmann, M. Schwaiger, K.T. Preissner, D.D. Wagner, N. Mackman, B. Engelmann, and S. Massberg Monocytes neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo J. Exp. Med. 209 2012 819 835
7. T.A. Fuchs, A. Brill, and D.D. Wagner Neutrophil extracellular trap (NET) impact on deep vein thrombosis Arterioscler. Thromb. Vasc. Biol. 32 2012 1777 1783
8. K. Martinod, and D.D. Wagner Thrombosis: tangled up in NETs Blood 123 2014 2768 2776
9. C. Patrono, and B. Rocca Aspirin: 110 years later J. Thromb. Haemost. 1 7 Suppl 2009 258 261
10. S. Reagan-Shaw, M. Nihal, and N. Ahmad Dose translation from animal to human studies revisited FASEB J. 22 2008 659 661
11. Z. Zhang, R. Vezza, T. Plappert, P. McNamara, J.A. Lawson, S. Austin, D. Pratico, M.S. Sutton, and G.A. FitzGerald COX-2-dependent cardiac failure in Gh/tTG transgenic mice Circ. Res. 92 2003 1153 1161
12. J.A. Diaz, D.M. Farris, S.K. Wrobleski, D.D. Myers, and T.W. Wakefield Inferior vena cava branch variations in C57BL/6 mice have an impact on thrombus size in an IVC ligation (stasis) model J. Thromb. Haemost. 13 2015 660 664
13. V. Cavalca, F. Minardi, S. Scurati, F. Guidugli, I. Squellerio, F. Veglia, L. Dainese, A. Guarino, E. Tremoli, and D. Caruso Simultaneous quantification of 8-iso-prostaglandin-f(2alpha) and 11-dehydro thromboxane B(2) in human urine by liquid chromatography-tandem mass spectrometry Anal. Biochem. 397 2010 168 174
14. S.S. Barbieri, P. Amadio, S. Gianellini, E. Tarantino, E. Zacchi, F. Veglia, L.R. Howe, B.B. Weksler, L. Mussoni, and E. Tremoli Cyclooxygenase-2-derived prostacyclin regulates arterial thrombus formation by suppressing tissue factor in a sirtuin-1-dependent-manner Circulation 126 2012 1373 1384
15. P. Amadio, D. Baldassarre, E. Tarantino, E. Zacchi, S. Gianellini, I. Squellerio, M. Amato, B.B. Weksler, E. Tremoli, and S.S. Barbieri Production of prostaglandin E2 induced by cigarette smoke modulates tissue factor expression and activity in endothelial cells FASEB J. 29 2015 4001 4010
16. S.S. Barbieri, G. Petrucci, E. Tarantino, P. Amadio, B. Rocca, M. Pesce, K.R. Machlus, F.O. Ranelletti, S. Gianellini, B. Weksler, J.E. Italiano Jr., and E. Tremoli Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice Thromb. Haemost. 114 2015
17. S. Eligini, S.S. Barbieri, I. Arenaz, E. Tremoli, and S. Colli Paracrine up-regulation of monocyte cyclooxygenase-2 by platelets: role of transforming growth factor-beta1 Cardiovasc. Res. 74 2007 270 278
18. J.A. Diaz, T.A. Fuchs, T.O. Jackson, J.A. Kremer Hovinga, B. Lammle, P.K. Henke, D.D. Myers Jr., D.D. Wagner, and T.W. Wakefield Plasma DNA is elevated in patients with deep vein thrombosis J. Vasc. Surg. Venous. Lymphat. Disord. 1 2013
19. T.A. Klotz, L.S. Cohn, and R.D. Zipser Urinary excretion of thromboxane B2 in patients with venous thromboembolic disease Chest 85 1984 329 335
20. P. Patrignani, C. Di Febbo, S. Tacconelli, K. Douville, M.D. Guglielmi, R.J. Horvath, M. Ding, K. Sierra, J. Stitham, S. Gleim, G. Baccante, V. Moretta, L. Di Francesco, M.L. Capone, E. Porreca, and J. Hwa Differential association between human prostacyclin receptor polymorphisms and the development of venous thrombosis and intimal hyperplasia: a clinical biomarker study Pharmacogenet. Genomics 18 2008 611 620
21. J. Kooiman, P.L. den Exter, I. Kilicsoy, S.C. Cannegieter, J. Eikenboom, M.V. Huisman, F.A. Klok, and H.H. Versteeg Association between micro particle-tissue factor activity: factor VIII activity and recurrent VTE in patients with acute pulmonary embolism J. Thromb. Thrombolysis. 40 2015 323 330
22. J. Thaler, R. Koppensteiner, I. Pabinger, C. Ay, and T. Gremmel Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one year Thromb. Res. 134 2014 1093 1096
23. J.M. Walenga, P.C. Kaiser, M.M. Prechel, D. Hoppensteadt, W.P. Jeske, F. Misselwitz, P. Bacher, M.R. Lassen, and J. Fareed Sustained release of tissue factor following thrombosis of lower limb trauma Clin. Appl. Thromb. Hemost. 20 2014 678 686
24. R. Ye, C. Ye, Y. Huang, L. Liu, and S. Wang Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis Thromb. Res. 130 2012 253 258
25. E. Ramacciotti, A.E. Hawley, D.M. Farris, N.E. Ballard, S.K. Wrobleski, D.D. Henke, P.K. Myers Jr., and T.W. Wakefield Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis Thromb. Haemost. 101 2009 748 754
26. J.E. Geddings, Y. Hisada, Y. Boulaftali, T.M. Getz, M. Whelihan, R. Fuentes, R. Dee, B.C. Cooley, N.S. Key, A.S. Wolberg, W. Bergmeier, and N. Mackman Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice J. Thromb. Haemost. 2015 10.1111/jth.13181
27. P. Patrignani, P. Filabozzi, and C. Patrono Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects J. Clin. Invest. 69 1982 1366 1372
28. A. Schmitt, J. Guichard, J.M. Masse, N. Debili, and E.M. Cramer Of mice and men: comparison of the ultrastructure of megakaryocytes and platelets Exp. Hematol. 29 2001 1295 1302
29. C. Baigent, L. Blackwell, R. Collins, J. Emberson, J. Godwin, R. Peto, J. Buring, C. Hennekens, P. Kearney, T. Meade, C. Patrono, M.C. Roncaglioni, and A. Zanchetti Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet 373 2009 1849 1860
30. A. Caudrillier, K. Kessenbrock, B.M. Gilliss, J.X. Nguyen, M.B. Marques, M. Monestier, P. Toy, Z. Werb, and M.R. Looney Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury J. Clin. Invest. 122 2012 2661 2671
31. S. Del Turco, G. Basta, G. Lazzerini, L. Chancharme, L. Lerond, and R. De Caterina Involvement of the TP receptor in TNF-alpha-induced endothelial tissue factor expression Vascul. Pharmacol. 62 2014 49 56
32. S. Eligini, F. Violi, C. Banfi, S.S. Barbieri, M. Brambilla, M. Saliola, E. Tremoli, and S. Colli Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism Cardiovasc. Res. 69 2006 218 226
33. S. He, N. Bark, H. Wang, J. Svensson, and M. Blomback Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis J. Cardiovasc. Pharmacol. 53 2009 24 29
34. S. Williams, K. Fatah, T. Ivert, and M. Blomback The effect of acetylsalicylic acid on fibrin gel lysis by tissue plasminogen activator Blood Coagul. Fibrinolysis 6 1995 718 725
35. C. Patrono The multifaceted clinical readouts of platelet inhibition by low-dose aspirin J. Am. Coll. Cardiol. 66 2015 74 85